Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Heather Vezina"'
Autor:
Quincy Siu-Chung Chu, Chunsheng He, Heather Vezina, Michelle Brown, Takafumi Koyama, Armando Santoro, Giuseppe Curigliano, Matteo Duca, Paul de Souza, Sandip Pravin Patel, Martijn Lolkema, Michael Millward, Kimberley M. Heinhuis, Ben Markman, Jean-Pascal Machiels, Kyaw Aung, Jeffrey Clarke, Sylvie Rottey
Supplementary Data from Phase I/IIa Trial of BMS-986148, an Anti-mesothelin Antibody–drug Conjugate, Alone or in Combination with Nivolumab in Patients with Advanced Solid Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02e637e39d766802f509fae320b24b17
https://doi.org/10.1158/1078-0432.22483182.v1
https://doi.org/10.1158/1078-0432.22483182.v1
Autor:
Quincy Siu-Chung Chu, Chunsheng He, Heather Vezina, Michelle Brown, Takafumi Koyama, Armando Santoro, Giuseppe Curigliano, Matteo Duca, Paul de Souza, Sandip Pravin Patel, Martijn Lolkema, Michael Millward, Kimberley M. Heinhuis, Ben Markman, Jean-Pascal Machiels, Kyaw Aung, Jeffrey Clarke, Sylvie Rottey
Purpose:To assess the safety and tolerability of BMS-986148, a mesothelin-directed antibody–drug conjugate (ADC) ± nivolumab, in patients with selected tumors.Patients and Methods:In an international phase I/IIa study [NCT02341625 (CA008-002)], pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2c2fc4b7537db73d7937cafbc350676
https://doi.org/10.1158/1078-0432.c.6531093.v1
https://doi.org/10.1158/1078-0432.c.6531093.v1
Autor:
Matias Rodrigo Chacon, Hernan J. Cutuli, Sergio Bracarda, Marco Maruzzo, Maria Teresa Bourlon, Carmel Jacobs, Begoña Pérez-Valderrama, Ignacio Magri, Martin Richardet, Piotr Centkowski, Simon Yuen Fai Fu, Pablo Gurman, Srivani Konduri, Zhuoxin Yu, Heather Vezina, Saby George, Laurence Albiges
Publikováno v:
Journal of Clinical Oncology. 40:TPS4621-TPS4621
TPS4621 Background: Nivolumab (NIVO), a programmed death-1 immune checkpoint inhibitor, has demonstrated clinical efficacy across patients with different tumor types, including clear cell renal cell carcinoma (ccRCC), when administered via IV infusio
Autor:
K. Rivet Amico, B. R. Simon Rosser, Mark L. Williams, Gene P. Danilenko, Keith J. Horvath, Jane M. Simoni, J. Michael Oakes, Heather Vezina
This study describes the results of an online social support intervention, called “Thrive with Me” (TWM), to improve antiretroviral therapy (ART) adherence. HIV-positive gay or bisexually-identified men self-reporting imperfect ART adherence in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11555e1ae495e60e59df88f03ccbd73e
https://europepmc.org/articles/PMC3674213/
https://europepmc.org/articles/PMC3674213/
Autor:
Singh, Renu, Kozhich, Alexander, Pan, Chin, Lee, Francis, Cardarelli, Pina, Vangipuram, Rangan, Iyer, Rama, Marathe, Punit
Publikováno v:
Biopharmaceutics & Drug Disposition; Nov2020, Vol. 41 Issue 8/9, p319-333, 15p
Publikováno v:
Clinical Pharmacology & Therapeutics; Jan2019, Vol. 105 Issue 1, p16-21, 6p
Publikováno v:
Immunotherapy Weekly; 2024, p1484-1484, 1p
Publikováno v:
Journal of Pharmacokinetics & Pharmacodynamics; Oct2017 Supplement, Vol. 44, p3-9, 7p
Publikováno v:
Journal of Clinical Pharmacology; Oct2017 Supplement S10, Vol. 57, pS11-S25, 15p
Publikováno v:
British Journal of Clinical Pharmacology; Aug2014, Vol. 78 Issue 2, p343-352, 10p